What is the typical dose of Fresh Frozen Plasma (FFP) for a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fresh Frozen Plasma Dosing

The standard dose of Fresh Frozen Plasma (FFP) is 10-15 ml/kg body weight, which translates to approximately 2-4 units (500-1000 ml) for an average 70 kg adult. 1

Standard Dosing Algorithm

Initial Dose for Active Bleeding with Coagulopathy

  • Administer 10-15 ml/kg as the initial dose when treating coagulopathy with active bleeding 1, 2
  • For a 70 kg patient, this equals approximately 700-1050 ml, or 3-4 units of FFP (each unit contains 250-300 ml) 1, 2
  • Doses below 10 ml/kg are unlikely to achieve the 30% factor concentration threshold needed for hemostasis and should be avoided 1, 2

Massive Hemorrhage Protocol

  • In massive transfusion scenarios (>10 units RBC in 24 hours or >6 units in 6 hours), maintain a 1:1 ratio of FFP:RBC until coagulation results become available 1, 2
  • This high-ratio transfusion strategy should ideally approach 1:1 in trauma patients to prevent dilutional coagulopathy 1

Warfarin Reversal (Non-Bleeding or Minor Bleeding)

  • Lower doses of 5-8 ml/kg FFP are usually sufficient for urgent warfarin reversal, representing approximately 1-2 units for most adults 1
  • However, prothrombin complex concentrate (PCC) should be preferred over FFP for warfarin reversal when available, as it is faster and more effective 1, 3

Critical Dosing Thresholds and Laboratory Targets

When to Transfuse FFP

  • FFP is indicated when PT >1.5 times normal (or INR >2.0), or aPTT >2 times normal with active microvascular bleeding 1
  • Do not transfuse FFP to correct laboratory values alone without bleeding, as this exposes patients to unnecessary risks 1, 2

Dose-Response Relationship

  • Higher doses (8 ml/kg median) show better response than lower doses (4 ml/kg) in correcting coagulopathy 1
  • The standard therapeutic dose of 15 ml/kg achieves a minimum 30% concentration of plasma factors necessary for hemostasis 2

Administration Considerations

Infusion Rate

  • Infuse FFP as rapidly as clinically tolerated in acute bleeding situations, prioritizing rapid correction of coagulopathy over specific infusion rates 1, 2
  • The primary goal is rapid correction rather than adhering to a predetermined infusion rate 1

Thawing and Storage

  • FFP can be thawed using dry oven (10 minutes), microwave (2-3 minutes), or water bath (20 minutes) 1
  • Once thawed, FFP must be used within 30 minutes if removed from refrigeration, or can be stored at 4°C for up to 24 hours 1, 2

Blood Type Compatibility

  • FFP should be ABO-compatible with the recipient; use group AB if blood type is unknown 1, 2

Important Clinical Caveats

When NOT to Use FFP

  • Do not use FFP for volume expansion or hypovolemia—use crystalloids or colloids instead 1
  • Do not use FFP for prophylactic correction of abnormal coagulation tests prior to low-risk invasive procedures in hemodynamically stable patients 1
  • Do not use FFP to correct coagulopathy in cirrhotic patients without active bleeding, as it may increase portal pressure 1

Fibrinogen Replacement

  • FFP is inefficient for isolated fibrinogen replacement, as four units contain only approximately 2 g of fibrinogen 1, 2, 3
  • If fibrinogen is <1.5 g/L (or <2 g/L in obstetrics), prioritize cryoprecipitate or fibrinogen concentrate over FFP 1, 2, 3

Monitoring After Transfusion

  • Recheck coagulation parameters after FFP transfusion to determine the need for additional doses 1
  • Monitor hemoglobin and coagulation tests before and after administration 1

Serious Risks to Monitor

Major Complications

  • Transfusion-related acute lung injury (TRALI) is the most serious complication, with FFP being one of the most frequently implicated products 1, 3
  • Transfusion-associated circulatory overload (TACO), particularly concerning in neonates, elderly, and patients with cardiac dysfunction 1, 2
  • Citrate toxicity with massive transfusion leading to hypocalcemia and hypomagnesemia 1
  • ABO incompatibility reactions if blood type matching is not performed 1, 2
  • Infectious disease transmission and allergic reactions 1, 3

Special Populations

Obstetric Hemorrhage

  • Withhold FFP until 4 units of RBC have been transfused, unless early coagulopathy is diagnosed on testing 1
  • After 4 units RBC with ongoing bleeding, give 4 units FFP and maintain 1:1 ratio until results available 1

Factor X Deficiency

  • For factor X deficiency specifically, FFP dosing targets trough factor X levels above 10-20 IU/dL, using 20 ml/kg followed by 3-6 ml/kg twice daily 4
  • However, plasma-derived factor X concentrate or prothrombin complex concentrates are preferred over FFP when available 4

References

Guideline

Plasma Fresco Congelado: Uso y Administración

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fresh Frozen Plasma Dosing for Adult Cancer Patients with Coagulopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Fresh Frozen Plasma vs Cryoprecipitate: Key Differences and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.